US 9987350
Antigens and vaccines directed against human enteroviruses
granted A61KA61K2039/5256A61K2039/5258
Quick answer
US patent 9987350 (Antigens and vaccines directed against human enteroviruses) held by SENTINEXT THERAPEUTICS Sdn Bhd expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SENTINEXT THERAPEUTICS Sdn Bhd
- Grant date
- Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/5256, A61K2039/5258, A61K2039/70, A61K39/12